Network for Pharma Solutions

Contact

About us

The Network for Pharma Solutions - NetPhaSol, launched in May 2017, is a cooperation network focussing on drug discovery & development. It serves as a platform for research, development and marketing of new products, technologies and services in drug development. The primary focus are the first value chain stages of a drug development cycle - however, further development stages are not excluded.

Our Mission

One-Stop-Shop for Products, Technologies and Services in Drug Development.

Facts

Our Competencies

Our Members

Your Benefits

The network offers an attractive performance portfolio in the fields of

• Target identification &

   validation

• Drug discovery

• Medicinal chemistry

• Drug targeting & drug delivery

• Preclinical research

• Enabling technologies

to potential customers, partners and investors for participation and cooperation.

 

NetPhaSol is a German network of 47 partners (currently 27 companies and 20 scientific institutions), e.g. JPT Peptide Technologies (subsidiary of BioNTech AG) and 3B Pharmaceuticals.

 

Here you find a detailed list of our members and their competence portfolios.

Members of our network are supported in a targeted way in order to

• Submit promising applications

   for R&D projects

• Develop new products and

   technologies in joint projects

• Join forces in marketing and

  distribution

• Gain more market power and

   visibility

• Provide joint services and products

   for pharmaceutical industry

Dr. Christian RA Regenbrecht

Spokesman

info@cellphenomics.com

+49 30 9489 4420

Volker Erb

Network Manager

volker.erb@berlin-partner.de

+49 30 46302 515

 

Dr. Jasmin Podufall

Network Manager

jasmin.podufall@berlin-partner.de

+49 30 46302 542

Contact

Please contact us for further information:

Contact

Facts

Vision

About us

Initiated by:

Supported by:

© 2017 NetPhaSol.  Imprint

Facts

NetPhaSol is a German network of 47 partners (currently 27 companies and 20 scientific institutions), e.g. JPT Peptide Technologies (subsidiary of BioNTech AG) and 3B Pharmaceuticals.

 

Here you find a detailed list of our members and their competence portfolios.

Facts

Facts

Contact